Kang JH, Mori T, Kitazaki H, Niidome T, Takayama K, Nakanishi Y, Katayama Y. Serum protein kinase Cα as a diagnostic biomarker of cancers. Cancer Biomark 2013;13:99-103.
Yamada K, Takayama K, Kawakami S, Saruwatari K, Morinaga R, Harada T, Aragane N, Nagata S, Kishimoto J, Nakanishi Y, Ichinose Y. Phase II trial of erlotinib for Japanese patients with previousky treated non-small-cell lung cancer harboring EGFR mutations: Results of Lung Oncology Group in Kyushu(LOGiK0803) Japanese Journal of Clinical Oncology 2013;43:629-635.
Okamura K, Nagata N, Wakamatsu K, Yonemoto K, Ikegame S, Kajiki A, Takayama K, Nakanishi Y. Hypoalbuminemia and lymphocytopenia are predictive risk factors for in-hospital mortality in patients with tuberculosis. Inter Med 2013;52:439-444.
Okamura K, Takayama K, Izumi M, Harada T, Furuyama K, Nakanishi Y. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. Lung Cancer 2013;80:45-49.